Who makes Bilaxten oral dispersible tablets?

Bilaxten oral dispersible tablets is developed by Humanis Saglık Anonim Sirketi.

What development phase is Bilaxten oral dispersible tablets in?

Bilaxten oral dispersible tablets is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Bilaxten oral dispersible tablets

Humanis Saglık Anonim Sirketi · Phase 1 active Small molecule

At a glance

Generic name	Bilaxten oral dispersible tablets
Sponsor	Humanis Saglık Anonim Sirketi
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Bilaxten oral dispersible tablets CI brief — competitive landscape report
Bilaxten oral dispersible tablets updates RSS · CI watch RSS
Humanis Saglık Anonim Sirketi portfolio CI